Roche Diagnostics Hematology Business Development Manager Salary
The average Roche Diagnostics Hematology Business Development Manager earns an estimated $155,810 annually, which includes an estimated base salary of $124,343 with a $31,467 bonus. Roche Diagnostics Hematology's Business Development Manager compensation is $23,669 more than the US average for a Business Development Manager. Business Development Manager salaries at Roche Diagnostics Hematology can range from $55,000 - $306,000.
The Business Development Department at Roche Diagnostics Hematology earns $718 more on average than the Engineering Department.
Last updated 5 years ago.
- $124,343
- avg. base
- $31,467
- avg. bonus
Business Development Manager Salaries at Roche Diagnostics Hematology
Business Development Managers earn $3,557 more than Business Development Managers, and $52,531 less than Directors of Business Development.
Compensation at Roche Diagnostics Hematology by Department
The Business Development Department averages $718 more than the Engineering Department, and $13,298 less than the Product Department
Business Development Manager Compensation by Gender (All Companies)
The average female Business Development Manager at companies similar size to Roche Diagnostics Hematology reported making $151,865, while the average male Business Development Manager at similar sized companies reported making $160,499.
Business Development Manager Compensation by Ethnicity (All Companies)
The average Hispanic or Latino Business Development Manager at companies similar size to Roche Diagnostics Hematology reported making $180,546, while the average African American/Black Business Development Manager at similar sized companies reported making $121,400.
How Business Development Managers at Roche Diagnostics Hematology Rate Their Compensation
The majority of Business Development Managers at Roche Diagnostics Hematology believe they're not compensated fairly. 100% of Business Development Managers at Roche Diagnostics Hematology say they receive annual bonuses, and the majority (50%) are satisfied with their benefits. See more compensation ratings at Roche Diagnostics Hematology
